PMID- 17973163 OWN - NLM STAT- MEDLINE DCOM- 20080430 LR - 20211020 IS - 1432-2218 (Electronic) IS - 0930-2794 (Linking) VI - 22 IP - 3 DP - 2008 Mar TI - Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study. PG - 589-98 AB - OBJECTIVE: To evaluate the safety and feasibility in human subjects of a new transoral restrictive procedure for the treatment of obesity. METHODS: The protocol was approved by the institutional review boards (IRBs) of both centers involved, and all patients gave informed consent. Patients met established inclusion criteria for bariatric surgery. The TOGa system (Satiety Inc., Palo Alto, CA), a set of transoral endoscopically guided staplers, was used to create a stapled restrictive pouch along the lesser curve of the stomach. Patients were hospitalized overnight for observation and underwent barium upper gastrointestinal (UGI) the next morning. Post procedure, all patients were placed on a liquid diet for 1 month and asked to begin an exercise program. Follow-up was carried out at 1 week and 1, 3, 4, 5, and 6 months. RESULTS: Twenty one patients were enrolled [17 female, age 43.7 (22-57) years, BMI 43.3 (35-53) kg/m(2)]. Device introduction was completed safely in all patients. There were no serious adverse events (AEs). The most commonly reported procedure or device related adverse events were vomiting, pain, nausea, and transient dysphagia. At 6 month endoscopy, all patients had persistent full or partial stapled sleeves. Gaps in the staple line were evident in 13 patients. Patients lost an average 17.6 pounds at 1 month, 24.5 pounds at three months, and 26.5 pounds at 6 months post-treatment [excess weight loss (EWL) of 16.2%, 22.6%, and 24.4%, respectively]. CONCLUSIONS: There is great interest in new procedures for morbid obesity that could offer lower morbidity than current options. Early experience with the TOGa procedure indicates that this transoral approach may be safe and feasible. Further experience with the device and technique should improve anatomic and functional outcomes in the future. Additional studies are underway. FAU - Deviere, J AU - Deviere J AD - Department of Gastroenterology and Hepatopancreatology, ULB, Hopital Erasme, Route de Lennik 808, B-1070, Brussels, Belgium. jdeviere@ulb.ac.be FAU - Ojeda Valdes, G AU - Ojeda Valdes G FAU - Cuevas Herrera, L AU - Cuevas Herrera L FAU - Closset, J AU - Closset J FAU - Le Moine, O AU - Le Moine O FAU - Eisendrath, P AU - Eisendrath P FAU - Moreno, C AU - Moreno C FAU - Dugardeyn, S AU - Dugardeyn S FAU - Barea, M AU - Barea M FAU - de la Torre, R AU - de la Torre R FAU - Edmundowicz, S AU - Edmundowicz S FAU - Scott, S AU - Scott S LA - eng PT - Controlled Clinical Trial PT - Journal Article PT - Multicenter Study DEP - 20071101 PL - Germany TA - Surg Endosc JT - Surgical endoscopy JID - 8806653 SB - IM EIN - Surg Endosc. 2008 Mar;22(3):599 MH - Adult MH - Body Mass Index MH - Endoscopy/adverse effects/methods MH - Feasibility Studies MH - Female MH - Follow-Up Studies MH - Gastroplasty/*methods MH - Gastroscopy/adverse effects/*methods MH - Humans MH - Male MH - Middle Aged MH - Minimally Invasive Surgical Procedures/methods MH - Obesity, Morbid/diagnosis/*surgery MH - Postoperative Complications/physiopathology MH - Prospective Studies MH - *Quality of Life MH - Risk Assessment MH - Safety Management MH - Single-Blind Method MH - Treatment Outcome MH - Weight Loss EDAT- 2007/11/02 09:00 MHDA- 2008/05/01 09:00 CRDT- 2007/11/02 09:00 PHST- 2007/04/20 00:00 [received] PHST- 2007/10/09 00:00 [accepted] PHST- 2007/10/04 00:00 [revised] PHST- 2007/11/02 09:00 [pubmed] PHST- 2008/05/01 09:00 [medline] PHST- 2007/11/02 09:00 [entrez] AID - 10.1007/s00464-007-9662-5 [doi] PST - ppublish SO - Surg Endosc. 2008 Mar;22(3):589-98. doi: 10.1007/s00464-007-9662-5. Epub 2007 Nov 1.